YL202

· MediLink Therapeutics (Suzhou) Co., Ltd.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for YL202, covering 2024-11-15 to 2026-03-10. Get the full timeline:

Most recent: Clinical Trial Update: YL202 Versus Treatment of Physician's Choice in Patients With HR+/HER2- Breast Cancer [Phase 3]